Migraine Research Foundation Announces Winners of 2009 Research Grants

(PRWEB) September 5, 2009 -- The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to funding migraine research, today announced the winners of the 2009 research...

New Initiative to Support Pediatric Migraine Research Announced

New York, NY (PRWEB) March 21, 2009 -- Today, the http://www.migraineresearchfoundation.org [Migraine Research Foundation __title__ Migraine Research Foundation] (MRF) announced a new initiative to...

Migraine Sufferers Share Top 12 Tips for Dealing with Post-Holiday Headaches

Mountain View, CA (PRWEB) December 29, 2008 -- Stay hydrated, find time to sleep, and when all else fails, break out the Imitrex. These are some of the most highly rated tips posted in the Migraine...

Migraine Research Foundation Welcomes President of American Headache Society to Medical Advisory Board

New York, NY (PRWEB) June 18, 2008 -- The http://www.migraineresearchfoundation.org [Migraine Research Foundation __title__ Migraine Research Foundation] announced today that Dr. Fred Sheftell,...

Migraine Research Foundation Launches with Announcement of First Annual Research Grants

New York, NY (PRWEB) December 18, 2007 -- More than 30 million Americans suffer from migraine, yet research into the causes of migraine is both severely underfunded and neglected. Today, the...

MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment In Open-Label Trial And Completion Of ...

MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed patient treatment in a thorough QT trial, the last trial necessary to support a New Drug Application (NDA) for LEVADEX. At this time, all patients have been ...